Accelerating the dissolution of enteric coatings in the upper small intestine: Evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release

详细信息    查看全文

• 作者：Felipe J.O. Varum¹ ; Hamid A. Merchant² ; Alvaro Goyanes ; Pardis Assi ; Veronika Zboranov&aacute ; Abdul W. Basit ; ^{a.basit@ucl.ac.uk" class="auth_mail} ; ^{abdul.basit@pharmacy.ac.uk" class="auth_mail}
• 关键词：Gastro resistant coatings ; Bicarbonate buffers ; Biorelevant dissolution ; pH responsive polymers ; Hypromellose phthalate ; Enteric polymers
• 刊名：International Journal of Pharmaceutics
• 出版年：1 July 2014
• 年：2014
• 卷：468
• 期：1-2
• 页码：172-177
• 全文大小：453 K

文摘

Despite rapid dissolution in compendial phosphate buffers, gastro resistant (enteric coated) products can take up to 2 h to disintegrate in the human small intestine, which clearly highlights the inadequacy of the in vitro test method to predict in vivo behaviour of these formulations. The aim of this study was to establish the utility of a novel pH 5.6 bicarbonate buffer, stabilized by an Auto pH™ System, as a better surrogate of the conditions of the proximal small intestine to investigate the dissolution behaviour of standard and accelerated release enteric double coating formulations. Prednisolone tablets were coated with 3 or 5 mg/cm² of partially neutralized EUDRAGIT^® L 30 D-55, HP-55 or HPMC adjusted to pH 6 or 8. An outer layer of EUDRAGIT^® L 30 D-55 was applied at 5 mg/cm². For comparison purposes, a standard single layer of EUDRAGIT^® L 30 D-55 was applied to the tablets. Dissolution was carried out using USP II apparatus in 0.1 M HCl for 2 h, followed by pH 5.6 bicarbonate buffer. EUDRAGIT^® L 30 D-55 single-coated tablets showed a slow drug release with a lag time of 75 min in buffer, whereas release from the EUDRAGIT^® L 30 D-55 double-coated tablets was accelerated. These in vitro lag times closely match the in vivo disintegration times for these coated tablets reported previously. Drug release was further accelerated from modified double coatings, particularly in the case of coatings with a thinner inner layer of HP-55 or HPMC (pH 8 and KH₂PO₄). This study confirms that the pH 5.6 bicarbonate buffer system offers significant advantages during the development of dosage forms designed to release the drug in the upper small intestine.